Profile
Dr. Léopold Bertea is a Chief Technology Officer at Mendus AB. Dr. Bertea was previously employed as a Senior VP-Technical Operations Europe Region by Cellectis SA, an Executive Vice President-Bio Production Division by LFB Biotechnologies SASU, a Vice President by Sanofi, and a Chairman, President & Chief Executive Officer by CELLforCURE SASU.
He received his doctorate degree from Swiss Federal Institute of Technology.
Léopold Bertea active positions
| Companies | Position | Start |
|---|---|---|
| MENDUS AB | Chief Tech/Sci/R&D Officer | 2022-05-04 |
Former positions of Léopold Bertea
| Companies | Position | End |
|---|---|---|
CELLforCURE SASU
CELLforCURE SASU Pharmaceuticals: MajorHealth Technology Manufactures cell and gene therapies | Chief Executive Officer | 2019-10-31 |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology Manufactures biotechnological medicinal products | Corporate Officer/Principal | 2019-02-28 |
| SANOFI | Corporate Officer/Principal | 2015-07-31 |
| CELLECTIS S.A. | Corporate Officer/Principal | - |
Training of Léopold Bertea
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology Manufactures biotechnological medicinal products | Health Technology |
Cellectis SA
Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
CELLforCURE SASU
CELLforCURE SASU Pharmaceuticals: MajorHealth Technology Manufactures cell and gene therapies | Health Technology |
- Stock Market
- Insiders
- Léopold Bertea
















